Logo

People in the News: Alan Venook, Steven Weitman

Oct 03, 2013
Premium

People in the News: Alan Venook, Steven Weitman

Mirna Therapeutics has appointed Alan Venook and Steven Weitman to its scientific advisory board.

Venook is a researcher at the University of California, San Francisco, who specializes in gastrointestinal oncology. He was previously chairman of the National Cancer Institute's Hepatobiliary Task Force.

Weitman is the director of the Institute for Drug Development at the Cancer Therapy & Research Center. He previously served as CMO of Ilex Oncology.

Filed under

Gene Editing, Gene Silencing, & CRISPR
RNAi
miRNA
Companies: Mirna
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.